These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30359008)

  • 21. Siphonaxanthin, a Carotenoid From Green Algae, Inhibits Lipogenesis in Hepatocytes via the Suppression of Liver X Receptor α Activity.
    Zheng J; Li Z; Manabe Y; Kim M; Goto T; Kawada T; Sugawara T
    Lipids; 2018 Jan; 53(1):41-52. PubMed ID: 29446839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver X receptor α induces 17β-hydroxysteroid dehydrogenase-13 expression through SREBP-1c.
    Su W; Peng J; Li S; Dai YB; Wang CJ; Xu H; Gao M; Ruan XZ; Gustafsson JÅ; Guan YF; Zhang XY
    Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E357-E367. PubMed ID: 28270440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
    Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
    Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein kinase A suppresses sterol regulatory element-binding protein-1C expression via phosphorylation of liver X receptor in the liver.
    Yamamoto T; Shimano H; Inoue N; Nakagawa Y; Matsuzaka T; Takahashi A; Yahagi N; Sone H; Suzuki H; Toyoshima H; Yamada N
    J Biol Chem; 2007 Apr; 282(16):11687-95. PubMed ID: 17296605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemistepsin A inhibits T0901317-induced lipogenesis in the liver.
    Kim JK; Cho IJ; Kim EO; Lee DG; Jung DH; Ki SH; Ku SK; Kim SC
    BMB Rep; 2021 Feb; 54(2):106-111. PubMed ID: 32843130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner.
    Han X; Cui ZY; Song J; Piao HQ; Lian LH; Hou LS; Wang G; Zheng S; Dong XX; Nan JX; Wu YL
    Chem Biol Interact; 2019 Sep; 311():108794. PubMed ID: 31421115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diosgenin prevents high-fat diet-induced rat non-alcoholic fatty liver disease through the AMPK and LXR signaling pathways.
    Cheng S; Liang S; Liu Q; Deng Z; Zhang Y; Du J; Zhang Y; Li S; Cheng B; Ling C
    Int J Mol Med; 2018 Feb; 41(2):1089-1095. PubMed ID: 29207101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
    Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
    Hong Y; Choi SI; Hong E; Kim GH
    J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
    Jung YA; Kim HK; Bae KH; Seo HY; Kim HS; Jang BK; Jung GS; Lee IK; Kim MK; Park KG
    Exp Mol Med; 2014 Jan; 46(1):e73. PubMed ID: 24458133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model.
    Xu L; Kim JK; Bai Q; Zhang X; Kakiyama G; Min HK; Sanyal AJ; Pandak WM; Ren S
    Mol Pharmacol; 2013 Mar; 83(3):648-58. PubMed ID: 23258548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription.
    Yap F; Craddock L; Yang J
    Int J Biol Sci; 2011; 7(5):645-50. PubMed ID: 21647332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha.
    Ren L; Sun D; Zhou X; Yang Y; Huang X; Li Y; Wang C; Li Y
    J Ethnopharmacol; 2019 Mar; 232():176-187. PubMed ID: 30590197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of hepatic lipogenesis by asymmetric arginine methylation.
    Han HS; Choi BH; Jang SY; Choi S; Hwang GS; Koo SH
    Metabolism; 2024 Aug; 157():155938. PubMed ID: 38795769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of fish oil feeding and fasting on LXRalpha/RXRalpha binding to LXRE in the SREBP-1c promoter in mouse liver.
    Nakatani T; Katsumata A; Miura S; Kamei Y; Ezaki O
    Biochim Biophys Acta; 2005 Sep; 1736(1):77-86. PubMed ID: 16112614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of LXR signaling by SULT2B1b promotes liver regeneration after partial hepatectomy in mouse models of nonalcoholic fatty liver disease.
    Zhang X; Xu Y; Bai Q; Li X; Han J; Hou Y; Ji Y; Zhang Z
    Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G87-G96. PubMed ID: 32475129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of Hepatic Lipogenesis by Loliolide and Pinoresinol from
    Kim SY; Lee JY; Jhin C; Shin JM; Kim M; Ahn HR; Yoo G; Son YJ; Jung SH; Nho CW
    J Agric Food Chem; 2019 Nov; 67(45):12419-12427. PubMed ID: 31610126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism.
    Zhang X; Liu J; Su W; Wu J; Wang C; Kong X; Gustafsson JÅ; Ding J; Ma X; Guan Y
    J Diabetes; 2014 May; 6(3):212-20. PubMed ID: 23945440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An active metabolite of oltipraz (M2) increases mitochondrial fuel oxidation and inhibits lipogenesis in the liver by dually activating AMPK.
    Kim TH; Eom JS; Lee CG; Yang YM; Lee YS; Kim SG
    Br J Pharmacol; 2013 Apr; 168(7):1647-61. PubMed ID: 23145499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Na TY; Shin YK; Roh KJ; Kang SA; Hong I; Oh SJ; Seong JK; Park CK; Choi YL; Lee MO
    Hepatology; 2009 Apr; 49(4):1122-31. PubMed ID: 19105208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.